Tilaknagar Industries reported a consolidated net revenue of ₹1,046 crore for the quarter ended June 30, 2026, marking its first-ever quarterly crossing of the ₹1,000 crore threshold. This represents a 166% year-on-year increase from ₹394 crore in the prior year period, driven by a 172% jump in volumes to 8.7 million cases following the full-quarter impact of the Imperial Blue acquisition. Adjusted profit after tax (PAT), excluding exceptional items and amortization related to the acquisition, rose 52% to ₹76 crore. The company’s net debt increased to ₹2,100 crore from ₹1,911 crore in March 2026 due to complete working capital cycle investments, though management targets net debt below March 2026 levels by March 2027.

The Board of Directors approved the unaudited financial results on July 27, 2026. Statutory auditors Harshil Shah & Company issued a qualified conclusion due to the company's failure to carry out an impairment assessment of one of its ENA plants, despite indications of impairment. This qualification persists from the audited financial statements for the year ended March 31, 2026. Management expects to restart the grain distillery plant after incurring relevant capital expenditure, leading to the belief that no impairment is required.

Financial Performance

Consolidated revenue from operations stood at ₹1,046 crore for the quarter, compared to ₹394 crore in the year-ago period. Adjusted for subsidy income, net revenue was ₹1,026 crore, growing at 189%. EBITDA grew by 79% to ₹169 crore from ₹94 crore. Adjusted for subsidy income, EBITDA stood at ₹148 crore, representing a 166% year-on-year growth with a margin of 14.5%. Excluding the impact of inflationary pressure, the margin would have been approximately 17%.

Profit before tax increased by 9% to ₹96 crore. After accounting for exceptional items totaling ₹30.11 crore related to post-acquisition integration costs for the Imperial Blue business, and tax expenses, the reported net profit was ₹31.59 crore. However, adjusted PAT (excluding exceptional items and amortization on intangible assets related to the acquisition of Imperial Blue) increased by 52% YoY to ₹76 crore.

The following table summarises the key financial metrics for the quarter:

*Excluding exceptional items and amortization related to Imperial Blue acquisition.

Operational Highlights

Volumes grew by 172% year-on-year to reach 8.7 million cases. On a quarter-on-quarter basis, total volumes rose by 9%, led by Imperial Blue (IB), which recorded 17.7% growth. IB expanded its market share across India by approximately 150 basis points quarter-on-quarter, with significant improvements in North, West, and South regions. The brand crossed 2 million cases in both May and June 2026. Mansion House Brandy (MHB) reached 2.6 million cases, reflecting growth of over 7% year-on-year.

Mr. Amit Dahanukar, Chairman & Managing Director, stated that ~90% of IB operations have been transitioned out of the Transition Services & Manufacturing Agreement (TSMA), leaving only one state to be completed. Consequently, exceptional costs relating to the transition are expected to reduce significantly over the remainder of FY27, with average monthly TSMA expenses halving to ~₹8 crore.

Balance Sheet and Debt Structure

The company’s gross debt decreased slightly to ₹2,241 crore from ₹2,295 crore in March 2026, primarily due to a reduction in working capital loans from ₹230 crore to ₹175 crore. However, cash and cash equivalents dropped significantly from ₹384 crore to ₹141 crore, resulting in an increase in net debt to ₹2,100 crore. The term loan component remained stable at ₹2,041 crore. This term loan has a six-year period with a two-year principal moratorium, followed by a balloon repayment structure where 65% of the principal is due in the sixth year. The effective interest rate on the term loan is ~10%-11%.

What the Numbers Show

The significant surge in revenue underscores the successful integration of Imperial Blue. While reported EBITDA margin contracted to 14.5% (adjusted for subsidy) from higher levels in previous periods, this reflects inflationary pressures on packaging inputs, particularly glass. These pressures were partly offset by softened Extra Neutral Alcohol (ENA) prices. Management projects an improvement upon the 15.5% baseline EBITDA margin achieved in Q4 FY26, supported by cost optimization initiatives. The reduction in exceptional integration costs going forward suggests normalized operating margins may be higher than currently reported. Additionally, cost savings from packaging changes and customs reductions under the India-UK FTA are expected to contribute 250–400 basis points in margin expansion on the acquired business.

Corporate Developments

The Board appointed Ms. Bhumika Batra as an Additional Independent Director for a term of three years, commencing July 27, 2026, subject to shareholder approval. Additionally, the Board approved the incorporation of a wholly-owned subsidiary in Nigeria, pending regulatory approvals. The company continues to pursue the Composite Scheme of Amalgamation involving subsidiaries Punjab Expo Breweries Private Limited and Vahni Distilleries Private Limited, awaiting approvals from shareholders, creditors, and the National Company Law Tribunal (NCLT). Tilaknagar also increased its stake in Bartisans to 41.45% through a ₹2 crore primary infusion, aiming to capitalize on the growing cocktail culture and q-commerce momentum.

Tilaknagar Industries has initiated a postal ballot process to seek shareholder approval for the re-appointment of Ms. Swapna Shah as a Non-Executive Non-Independent Director. The move aims to retain her strategic leadership in business development and operations for another term, subject to member consent through remote e-voting.

The proposal was placed before members pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 110 of the Companies Act, 2013. The Board of Directors approved the recommendation following a review by the Nomination and Remuneration Committee during its meeting on May 29, 2026. The postal ballot notice was dispatched electronically to registered members as of the cut-off date.

Voting Timeline and Process

Shareholders holding shares as of the cut-off date of Friday, July 17, 2026, are eligible to vote. The remote e-voting facility is provided by Central Depository Services (India) Limited (CDSL). Members must cast their votes electronically; physical ballot forms are not being distributed in compliance with Ministry of Corporate Affairs circulars.

Advocate R. T. Rajguroo, Advocate High Court, has been appointed as the Scrutiniser to oversee the voting process. The results will be declared within two working days of the conclusion of the voting period.

Tenure and Remuneration Details

Ms. Shah, who holds a Master’s in Business Administration from the University of Missouri and studied International Business Management at Kellogg School of Management, has been associated with the company since July 2020. Her re-appointment is proposed for a period of one year, commencing June 1, 2026, and ending May 31, 2027.

The Board seeks approval for advisory fees not exceeding ₹2,50,000 per month, excluding applicable taxes. This aligns with the remuneration structure approved by members at the 89th Annual General Meeting held on September 27, 2024. During the financial year 2025-2026, she received an advisory fee of ₹1,50,000 per month along with sitting fees totaling ₹7,25,000. She holds no shareholding in the company and has no relationships with other directors or key managerial personnel.

What the Numbers Show

The continuity in the proposed advisory fee cap of ₹2,50,000 per month reflects the Board’s adherence to the previously approved remuneration framework, despite actual disbursements in FY25-26 being lower at ₹1,50,000 per month. This suggests that the approved ceiling serves as a maximum limit rather than a fixed payout, allowing flexibility based on engagement levels while maintaining governance consistency established in the prior two-year tenure approval.